Related Experiment Video
Updated: Mar 25, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future
Carmela Santangelo1, Alessandra Zicari2, Elisabetta Mandosi3
11Department of Veterinary Public Health and Food Safety,Unit of Nutrition,Italian National Institute of Health,Viale Regina Elena 299,00161 Rome,Italy.
Dietary bioactive compounds like polyphenols may help manage gestational diabetes mellitus (GDM). Research suggests these compounds influence glucose homeostasis, but more human studies are needed for GDM outcomes.
Area of Science:
- Nutrition Science
- Endocrinology
- Molecular Biology
Background:
- Gestational diabetes mellitus (GDM) is a growing global health concern with severe maternal and fetal complications.
- Dietary interventions, particularly those rich in fruits, vegetables, nuts, olive oil, and fish, show promise in disease prevention and management.
- Understanding the molecular mechanisms of dietary compounds is crucial for metabolic health.
Purpose of the Study:
- To review current data on dietary bioactive compounds and their impact on glucose homeostasis.
- To explore the molecular mechanisms by which polyphenols and polyunsaturated fatty acids (PUFAs) affect insulin signaling and glucose regulation.
- To highlight the need for further research into dietary interventions for GDM.
Main Methods:
- Literature review of in vitro and animal studies on dietary bioactive compounds.
- Analysis of research on polyphenols, particularly flavonoids, and their effects on insulin signaling pathways.
- Examination of data regarding microRNA (miRNA) profiles and inflammatory adipokines in relation to diet.
Main Results:
- Dietary polyphenols, especially flavonoids, demonstrate positive modulation of insulin signaling.
- These compounds show potential in attenuating hyperglycemia and insulin resistance.
- Evidence suggests effects on reducing inflammatory adipokines and modifying miRNA profiles.
Conclusions:
- Dietary bioactive compounds, such as polyphenols, show promise in influencing molecular mechanisms of glucose homeostasis.
- While in vitro and animal studies are informative, robust clinical data on GDM outcomes are limited.
- Further 'omics' research is essential to elucidate the complex interactions between diet and GDM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
